CompletedNot Applicable

Topical Cosmetic Products for Hand and Foot Syndrome

Italy53 participantsStarted 2022-08-31

Plain-language summary

The aim of the study is to evaluate the efficacy of a dermocosmetic protocol in reducing the main cutaneous side effects that occur in palmar-plantar erythrodysesthesia syndrome in subjects with a tumor diagnosis, undergoing chemotherapy and targeted treatments such as target therapy and radiotherapy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Cancer diagnosis undergoing oncological therapy with chemotherapeutic agents, targeted therapy, immunotherapy hormonal treatments * Patients with grade 1 of Hand-foot syndrome (HFS) Male and female patients 18 age or more * Conditions favoring the correct execution of the proposed program * Signature of informed consent, privacy and the form for the use of the data Exclusion Criteria: * Pregnancy or breastfeeding in progress * Other skin toxixities different from HFS * Patients with HFS adverse skin symptoms higher than grade 1 * Psychic or other disorderes * Patients with preexisting skin disorders thet could interfere with thw study results (like dermatitis, prosriais) * Known hypersensitivity or allergy to one of the components of the products

What they're measuring

Change from Baseline in the mean skin hydration index at 45 days

Timeframe: Baseline and 45 days

Trial details

NCT IDNCT06586073

SponsorDermophisiologique s.r.l

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2023-11-30

View on ClinicalTrials.gov More Hand Foot Skin Syndrome trials